GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Huangshan Capsule Co Ltd (SZSE:002817) » Definitions » Research & Development

Anhui Huangshan Capsule Co (SZSE:002817) Research & Development : ¥13.9 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Anhui Huangshan Capsule Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Anhui Huangshan Capsule Co's Research & Development for the three months ended in Mar. 2025 was ¥3.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥13.9 Mil.


Anhui Huangshan Capsule Co Research & Development Historical Data

The historical data trend for Anhui Huangshan Capsule Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Huangshan Capsule Co Research & Development Chart

Anhui Huangshan Capsule Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.35 13.44 14.98 15.77 14.01

Anhui Huangshan Capsule Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.61 3.06 3.50 3.83 3.46

Anhui Huangshan Capsule Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥13.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Huangshan Capsule Co  (SZSE:002817) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Anhui Huangshan Capsule Co Research & Development Related Terms

Thank you for viewing the detailed overview of Anhui Huangshan Capsule Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Huangshan Capsule Co Business Description

Traded in Other Exchanges
N/A
Address
Baidihongchuan, Jingde County, Anhui Province, Xuancheng, CHN, 242600
Anhui Huangshan Capsule Co Ltd is engaged in the development, production and sales of gelatin hollow capsules and enteric gelatin hollow capsules in China. It products portfolio includes Entersoluble vacant gelatin capsules, Vegetable capsule, Pulluan capsule, Vacant gelatin capsule and Vegetable entersoluble capsule.
Executives
Yu Chun Ming Director
Zhu Guan Run Supervisors
Liu Song Lin Supervisors
Wang Hong Shi Directors, executives
Ye Song Lin Directors, executives

Anhui Huangshan Capsule Co Headlines

No Headlines